These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1499006)

  • 1. Pharmacokinetics of fluoxetine and fluvoxamine in depressed patients: personal results.
    Bouquet S; Vandel S; Bertschy G; Bonin B; Vandel B; Sechter D; Bizouard P
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():82A-83A. PubMed ID: 1499006
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
    Strauss WL; Unis AS; Cowan C; Dawson G; Dager SR
    Am J Psychiatry; 2002 May; 159(5):755-60. PubMed ID: 11986128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent clearance decrements of fluvoxamine in depressed inpatients: a clinical evaluation.
    van den Broek WW; Birkenhäger TK; Mulder PG; Mathot RA; Bruijn JA; Moleman P
    J Clin Psychopharmacol; 2007 Apr; 27(2):231-3. PubMed ID: 17414260
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients.
    Vandel S; Bertschy G; Baumann P; Bouquet S; Bonin B; Francois T; Sechter D; Bizouard P
    Pharmacol Res; 1995 Jun; 31(6):347-53. PubMed ID: 8685072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy.
    Bolo NR; Hodé Y; Nédélec JF; Lainé E; Wagner G; Macher JP
    Neuropsychopharmacology; 2000 Oct; 23(4):428-38. PubMed ID: 10989270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium valproate augmentation of fluoxetine or fluvoxamine effects.
    Corrigan FM
    Biol Psychiatry; 1992 Jun; 31(11):1178-9. PubMed ID: 1525286
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
    Tulloch IF; Johnson AM
    J Clin Psychiatry; 1992 Feb; 53 Suppl():7-12. PubMed ID: 1531829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the selective serotonin reuptake inhibitors.
    DeVane CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():13-20. PubMed ID: 1531816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapy.
    Miljković BR; Pokrajac M; Timotijević I; Varagić V
    Int Clin Psychopharmacol; 1997 Jul; 12(4):207-12. PubMed ID: 9347381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone.
    Eap CB; Bertschy G; Powell K; Baumann P
    J Clin Psychopharmacol; 1997 Apr; 17(2):113-7. PubMed ID: 10950475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonlinear pharmacokinetics of fluvoxamine and gender differences.
    Härtter S; Wetzel H; Hammes E; Torkzadeh M; Hiemke C
    Ther Drug Monit; 1998 Aug; 20(4):446-9. PubMed ID: 9712472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder.
    Strauss WL; Layton ME; Hayes CE; Dager SR
    Am J Psychiatry; 1997 Apr; 154(4):516-22. PubMed ID: 9090339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are SSRI antidepressants clinically homogeneous?
    Carroll BJ
    Lancet; 1994 Aug; 344(8921):550. PubMed ID: 7914647
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients.
    Härtter S; Wetzel H; Hammes E; Hiemke C
    Psychopharmacology (Berl); 1993; 110(3):302-8. PubMed ID: 7831423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of serotonin uptake inhibitors: focus on fluvoxamine.
    Hrdina PD
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):10-8. PubMed ID: 1931931
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic fluvoxamine-clomipramine interaction with favorable therapeutic consequences in therapy-resistant depressive patient.
    Conus P; Bondolfi G; Eap CB; Macciardi F; Baumann P
    Pharmacopsychiatry; 1996 May; 29(3):108-10. PubMed ID: 8738315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].
    Lopukhov IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(4):53-7. PubMed ID: 9214192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy.
    Mann JJ; Kapur S
    Arch Gen Psychiatry; 1991 Nov; 48(11):1027-33. PubMed ID: 1747018
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term sequestration of fluorinated compounds in tissues after fluvoxamine or fluoxetine treatment: a fluorine magnetic resonance spectroscopy study in vivo.
    Bolo NR; Hodé Y; Macher JP
    MAGMA; 2004 May; 16(6):268-76. PubMed ID: 15042463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluoxetine versus fluvoxamine for treatment of chronic pain].
    Ciaramella A; Grosso S; Poli P
    Minerva Anestesiol; 2000; 66(1-2):55-61. PubMed ID: 10736983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.